Konu "Relapsed/Refractory Diffuse Large B‐Cell Lymphoma" için Makale Koleksiyonu listeleme
Toplam kayıt 1, listelenen: 1-1
-
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
(Wiley, 2023)Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and survival rates were recently reported in a pivotal phase II expansion ...